arrow
M

Maddalena Arigoni

Molecular Biotechnology Center Guido Tarone
H指数:28
被引数:2,095

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Interleukin-1 receptor-associated kinase 1 controls chemoresistance and immuno-killing in non-small cell lung cancer

Interleukin-1受体相关激酶1控制非小细胞肺癌的化学抗性和免疫杀伤

2026-09-150
OAAI
FairFlow: A transparency-first framework for verifiable and reproducible bioinformatics

FairFlow:一个透明度优先的、用于可验证和可重复的生物信息学框架

Array
IF4.5
2026-08-140
OAAI
Unraveling lung cancer dynamics: a new metabolic signature improving the prediction of recurrence in resected lung adenocarcinoma

揭示肺癌动态变化:一种新的代谢特征可改善切除后肺腺癌复发的预测

2026-03-100
OAAI
The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenocarcinoma

IL17A的缺失有利于细胞毒性细胞功能,并改善胰腺腺癌中的抗原特异性免疫疗法

2025-08-190
OA
miRNA-503 inhibition exerts anticancer effects and reduces tumor growth in mesothelioma

miRNA-503抑制表现出抗癌作用并降低间皮瘤肿瘤生长

2025-02-220
OA
Extracellular Vesicle-Enclosed Oxidative Stress- and Inflammation-Related microRNAs as Potential Biomarkers of Vitamin D Responsivity: A Pilot Study on Inflammatory Bowel Disease Patients with or without COVID-19
2024-08-280
OAAI
In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector response to tumor-associated antigens

在胰腺癌患者中,化疗重塑了T淋巴细胞的基因表达谱和抗原受体谱系,并增强了它们对肿瘤相关抗原的效应子反应

2024-08-081
OAAI
Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cells
2024-06-071
OAAI
Targeting CCR7-PI3K? overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma
2023-06-286
PRE
Extracellular Vesicles Derived From Plasma of Patients With Neurodegenerative Disease Have Common Transcriptomic Profiling

来自神经退行性疾病患者血浆的细胞外囊泡具有共同的转录组图谱

2022-02-1616
OAAI